STOCK TITAN

Arcus Biosciences, Inc. (RCUS) Net Income by Year

RCUS

Arcus Biosciences, Inc. reported a net loss of $353.0M in fiscal year 2025. This represents a decrease of 24.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $460.0M net loss. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Arcus Biosciences, Inc. has filed alongside them.

FY2025 annual
Net Income -$353.0M
YoY -24.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RCUS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Net Income-$460.0M-$353.0M-24.7%-$283.0M+7.8%-$307.0M-15.0%-$267.0M-603.8%$53.0M+143.1%-$123.0M-45.2%-$84.7M-70.8%-$49.6M+6.6%-$53.1M-195.4%-$18.0M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

RCUS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$91.0M-$128.0M-14.3%-$106.0M-12.8%-$135.0M-46.7%$0+100.0%-$112.0M-2700.0%-$94.0M-16.0%-$92.0M-29.6%-$93.0M-24.0%-$4.0M+95.0%-$81.0M-20.9%-$71.0M-9.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Arcus Biosciences, Inc. financials

Frequently Asked Questions

What was Arcus Biosciences, Inc.'s net income in fiscal year 2025?

Arcus Biosciences, Inc. reported a net loss of $353.0M in fiscal year 2025.

How fast is Arcus Biosciences, Inc.'s net income growing?

Arcus Biosciences, Inc. (RCUS) net income fell by 24.7% year over year, from -$283.0M to -$353.0M in fiscal year 2025.

What is Arcus Biosciences, Inc.'s net income over the last twelve months?

Arcus Biosciences, Inc. (RCUS) reported a $460.0M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 10 fiscal years this page covers, Arcus Biosciences, Inc. (RCUS) net income went from -$18.0M in fiscal year 2016 to -$353.0M in fiscal year 2025.

Arcus Biosciences, Inc. (RCUS) reported -$91.0M in net income in Q2 2026.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Arcus Biosciences, Inc. (RCUS) reported on that line in every period on record.